Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1997
12/09/1997US5696100 Anticancer agent
12/09/1997US5696088 Chimeric proteins
12/09/1997US5696086 Administering before or after chemotherapy to promote thrombocyte production, also kits
12/09/1997US5695755 Peripheralization of hematopoietic stem cells
12/09/1997CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/09/1997CA2028626C Process for producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
12/04/1997WO1997045550A2 Mini-adenoviral vector
12/04/1997WO1997045424A1 Aromatic amidine derivatives useful as selective thrombin inhibitors
12/04/1997WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997WO1997045138A1 New improved formulation for treatment of thromboembolism
12/04/1997WO1997045131A1 Compositions for use in embolizing blood vessels
12/04/1997WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997WO1997041206A3 Von willebrand factor multimerase
12/04/1997WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997CA2257148A1 Mini-adenoviral vector
12/04/1997CA2253410A1 New improved formulation for treatment of thromboembolism
12/04/1997CA2252718A1 Compositions for use in embolizing blood vessels
12/03/1997EP0810285A2 Mutants of human Interleukin-3
12/03/1997EP0809660A1 Polymeric compounds
12/03/1997EP0809651A1 Thrombin inhibitors
12/03/1997EP0809650A1 Serine protease inhibitors
12/03/1997EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997EP0809437A1 Thiols to promote hematopoietic progenitor cell growth
12/03/1997CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997US5693641 Enzyme inhibitor treating blood disorder
12/02/1997US5693636 Bicyclic fibrinogen antagonists
12/02/1997US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression
11/1997
11/27/1997WO1997044056A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
11/27/1997WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997WO1997044029A1 Methods of increasing nitric oxide synthesis
11/27/1997CA2255792A1 Methods of increasing nitric oxide synthesis
11/26/1997EP0808905A2 Adenoviral vector for the transfer of human genes in vivo
11/26/1997EP0808901A2 Pharmaceutical preparation with factor VIII procoagulant activity and vWF-binding activity
11/26/1997EP0808311A2 New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
11/26/1997EP0808306A1 New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
11/26/1997EP0808171A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
11/26/1997EP0808159A1 USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a)
11/25/1997US5691453 Blood substitutes
11/25/1997US5691387 Treatment of sickle cell anemia with nonionic surfactants
11/25/1997US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997US5691366 Unsaturated nitro oxime formed by reaction of dinitrogen trioxide with diolefin ether, sulfide or amine to be used as vasodilators
11/25/1997US5691364 Benzamidine derivatives and their use as anti-coagulants
11/25/1997US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997US5691160 Elution and quantitative analysis of actin in clots with incubation
11/25/1997US5690931 Method for treating thromboembolic conditions via the use of multiple bolus administration of thrombolytically active proteins
11/24/1997CA2205824A1 Pharmaceutical preparation with factor viii procoagulant activity and vwf binding activity
11/22/1997CA2205078A1 Novel adenoviral vector for transferring human genes in vivo
11/20/1997WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
11/20/1997WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
11/20/1997WO1997043309A1 Tsetse thrombin inhibitor
11/20/1997WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997WO1997042967A1 Antithrombotic materials and methods
11/20/1997WO1997042941A2 Buccal delivery system
11/20/1997CA2253851A1 Tsetse thrombin inhibitor
11/20/1997CA2253836A1 Antithrombotic materials and methods
11/19/1997EP0807638A1 Inhibitors and substrates of thrombin
11/19/1997EP0807632A1 Pyrroloazepine derivatives
11/19/1997EP0807181A1 NOVEL c-MPL LIGANDS
11/19/1997EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997EP0536177B1 Thrombin inhibitors based on the amino acid sequence of hirudin
11/19/1997CN1165477A Delivery of solid drug compositions
11/19/1997CN1165033A Isolation of novel peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
11/18/1997US5688815 Hydroxypyridinones
11/18/1997US5688813 2-phenyl-3-aroylbenzothiophenes
11/18/1997US5688768 Recombinant thrombin receptor and related pharmaceuticals
11/18/1997US5688767 Treatment of endotoxin-associated disorders with cationic peptides
11/18/1997US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants
11/18/1997US5688503 Modification of plasminogen activators
11/13/1997WO1997042224A1 Neurotactin and uses therefor
11/13/1997WO1997041857A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997WO1997033996A3 Human bikunin
11/13/1997WO1997027177A3 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
11/13/1997CA2253864A1 Neurotactin and uses therefor
11/13/1997CA2251969A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/12/1997EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997EP0600928B1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
11/12/1997CN1036399C Method for preparation of tripeptide antithrombotic agents
11/11/1997US5686583 Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
11/11/1997US5686576 Genetic engineering
11/11/1997US5686462 Anti-inflammatory method
11/11/1997US5686459 Anticoagulants
11/11/1997US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997US5686421 Hydantoin derivates
11/11/1997US5686278 Methods for enhanced retrovirus-mediated gene transfer
11/06/1997WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
11/06/1997WO1997041206A2 Von willebrand factor multimerase
11/06/1997WO1997041141A1 Methods and compounds for curing diseases caused by mutations
11/06/1997WO1997041102A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/06/1997WO1997040850A1 Erythropoietin solution preparation
11/06/1997WO1997040840A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent